RICERCA ITALIANA     

FIRB simili:

• 1 - I recettori metabotropi per il glutammato come target terapeutico nella neurodegenerazione associata ai disturbi del movimento
• 2 - Modelli di dipendenza: correlati molecolari e funzionali.
• 3 - Sviluppo di Tecnologie Avanzate per lo Studio della Proteomica Differenziale del Segnale (Segnalo-Proteomica)
• 4 - NUOVI RECETTORI E MEDIATORI DELL'IMMUNITA' INNATA
• 5 - Sviluppo di molecole innovative in grado di curare malattie neurodegenerative e neuroinfiammatorie.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze chimiche
  • CHIMICA FARMACEUTICA
• Area scientifico disciplinare: Scienze biologiche
  • BIOCHIMICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

Classificazione geografica

• Regione: Marche

Bibliografia

Abbracchio, M.P.; Boeynaems, J.M.; Barnard, E.A.; Boyer, J.L.; Kennedy, C.; Miras-Portugal, M.T.; King, B.F.; Gachet, C.; Jacobson, K.A.; Weisman, G.A.; Burnstock, G. (2003) Trends Pharm. Sci. 24, 52-55.
Abbracchio, M.P.; Boeynaems, J.M.; Barnard, E.A.; Boyer, J.L.; Kennedy, C.; Miras-Portugal, M.T.; King, B.F., Gachet, C.; Jacobson, K.A.; Weisman, G.A.; Burnstock, G. (2003) Trends Pharmacol. Sci. 24, 52-5.
Abbracchio, M.P.; Burnstock, G. (1994) Pharmacol. Ther. 64, 445-475.
Abbracchio, M.P.; Burnstock, G. (1998) Jpn. J. Pharmacol. 78, 113-145.
Andrasi, F. Talampanel.(2001) Drugs of the Future 26, 754-756.
Barreca, M. L.; Gitto,R.; Quartarone,S.;. De Luca,L.; De Sarro,G.; Chimirri A. (2003)
Bianchi, B.R.; Lynch, K.J.; Touma, E.; Niforatos, W.; Burgard, E.C.; Alexander, K.M.; Park, H.S.; Yu, H.; Metzger, R.; Kowaluk, E.; Jarvis, M.F.; van Biesen T. (1999) Eur. J. Pharmacol. 376, 127-138.
Boyer, J. L.; Romero-Avila, T.; Schachter, J. B.; Harden, T. K. (1996) Receptor. Mol. Pharmacol. 50, 1323-1329.
Burnstock, G.; Williams, M. (2000) J. Pharmacol. Exper. Ther. 295, 862-869.
Camaioni, E.: Di Francesco, E.; Vittori, S.; Volpini, R.; Cristalli, G. (1997) Bioorg. Med. Chem. 5 , 2267-2275.
Camaioni, E.; Boyer, J. L.; Mohanram, A.; Harden, T. K.; Jacobson, K.A (1998) J. Med. Chem. 41, 183-190.
Chimirri, A.; De Sarro, G.; De Sarro, A.; Gitto, R.; Grasso, S.; Quartarone, S; Zappalà, M; Giusti, P.; Libri, V; Constanti, A; Chapman, A.G. (1997) J. Med. Chem. 40, 1258-1269.
Chimirri, A.; Gitto, R.; Zappalà, M. (1999) Exp. Opin. Ther. Patents, 9, 557-570.
Costanzi, S.; Mamedova, L.; Gao, Z-G.; Jacobson, K.A. (2004) J. Med. Chem. Submitted
Cristalli, G. and Volpini, R (2003) Curr. Top. in Med. Chem. 3 (4): U2-U2.
Cristalli, G.; Camaioni, E.; Costanzi, S.; Vittori, S.; Volpini, R.; Klotz, K.N. (1998) Drug Develop. Res. 45, 176-181.
Cristalli, G.; Mills, D. C. B. (1993) Biochem. J. 291, 875-881.
Dalpiaz, A.; Scatturin, A.; Pavan, B.; Biondi, C.; Randelli, M. A.; Forni, F. (2002) Int. J. Pharm. 242 (1-2), 115-120.
Damer, S.; Niebel, B.; Czeche, S.; Nickel, P.; Ardamuy, U.; Schmalzing, G.; Rettinger, J.; Mutschler,E.; Lambrecht, G. (1998) Eur. J. Pharmacol. 350, R5-R6.
Danysz, W.; Parsons, C.G. (2002) Neurotox. Res. 4(2), 119-26.
Di Virgilio, F.; Chiozzi, P.; Falzoni, S.; Ferrari, D.; Sanz, J.M.; Venketaraman, V.; Baricordi, O.R. (1998) Cell Death Differ. 5(3), 191-9.
Domene, C.; Haider, S.; Sansom, M.S. (2003) Curr. Opin. Drug Discov. Devel. 6(5), 611-9.
Dubyak, G.R. (2003) Mol. Pharmacol. 63, 773-6.
Epple, R.; Kudirka, R.; Greenberg, W. A. (2003) J. Comb. Chem. 5, 292-310.
Fischer, B. (1999) Exp. Opin. Ther. Patents. 9, 385-399.
Fischer, B.; Yefidoff, R.; Major, D.T.; Tutman-Halili I.; Shneywvays, V.; Zinman, T.; Jacobson, K.A.; Shainberg, A. (1999) J. Med. Chem. 42, 2685-2696.
Fredholm, B.B.; Abbracchio, M.P.; Burnstock, G.; Dubyak, G.R.; Harden, T.K.; Jacobson, K.A.; Schwabe, U.; Williams, M. (1997) Trends Pharm. Sci. 18, 79-82.
Fredriksson, R.; Lagerstrom, M.C.; Lundin, L.G.; Schioth, H.B. (2003) Mol. Pharmacol. 63, 1256-72.
Gitto, R.;. Barreca, M. L.; De Luca,L.; De Sarro, G.; Ferreri,G.; Quartarone,S.; Russo,E.; Constanti, A.; Chimirri, A. (2003) J. Med. Chem., 46, 197-200.
Hechler, B.; Vigne, P.; Leon, C.; Breittmayer, J.P.; Gachet, C.; Frelin, C. (1998) Mol. Pharmacol. 53, 727-733.
Hibell, A.D.; Thompson, K.M.; Simon, J.; Xing, M.; Humphrey, P.P.; Michel, A.D. (2001) J. Pharmacol. Exp. Ther. 296, 947-957.
Hollopeter, G.; Jantzen, H.M.; Vincent, D.; Li, G.; England, L.; Ramakrishnan, V.; Yang, R.B.; Nurden, P.; Nurden, A.; Julius, D.; Conley, P.B. (2001) Nature 409, 202-207.
Howard, A.D.; McAllister, G.; Feighner, S.D.; Liu, Q.; Nargund, R.P.; VanDerPloeg, L.H.T.; Patchett, A. (2001) Trends Pharm. Sci. 22, 132-140.
Illes, P.; Klotz, K.-N.; Lose, M.J. (2000) Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 295-298.
Ito, A.; Tanaka, K., Honda, H.; Abe, S.; Yamaguchi, H.; Kobayashi, T. (2003) 96 (4), 364-369.
J. Chem. Inf. Comput. Sci., 43, 651-655.
Jacobson, K.A.; Jarvis, M.F.; Williams, M. (2002) J. Med. Chem. 45, 4057-4093.
Jacobson, K.A; Jarvis, M.F.; Williams, M. (2002) J Med Chem, 45(19), 4057-4093.
Khakh, B.S.; Burnstock, G.; Kennedy, C.; King, B.F.; North, R.A.; Seguela, P.; Voigt, M.; Humphrey, P.P. (2001) Pharmacol Rev. 53, 107-18.
Khakh, B.S.; Burnstock, G.; Kennedy, C.; King, B.F.; North, R.A.; Seguela, P.; Voigt, M.; Humphrey. P.P.A. (2001) Pharmacol. Rev. 53, 107-118.
Kim, Y-C.; Brown, S.G.; Harden, T.K.; Boyer, J.L.; Dubyak, G.; King, B.F.; Burnstock, G.; Jacobson, K.A. (2001) J. Med. Chem. 44, 340-349.
Knoblauch, B.H.A.; Muller, C.H.; Jarlebark, L.; Lawoko, G.; Kottke, T.; Wikstrom, M.A.; Heilbronn, E. (1999) Eur. J. Med. Chem. 34, 809-924.
Lambertucci, C.; Costanzi, S.; Vittori, S.; Volpini, R.; Cristalli, G. (2001) Nucleosides, Nucleotides & Nucleic Acid Chemistry 20, 1153-1157.
Lambrecht, G. (2000) Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 340-350.
Lambrecht, G.; Rettinger, J.; Baumert, H.G.; Czeche, S.; Damer, S.; Ganso, M.; Hildebrandt, C.; Niebel, B.; Spatz-Kumbel, G.; Schmalzing, G.; Mutschler,E. (2000) Eur. J. Pharmacol. 387, R19-R21.
Lazarowski, E.R.; Boucher, R.C.; Harden, T.K. (2000) J. Biol. Chem. 275, 31061-31068.
Lazarowski, E.R.; Watt W.C.; Stutts, M.J.; Boucher, R.C.; Harden, T.K. (1995) Br. J. Pharmacol. 116, 1619-1627.
Lohse, M.J. Klotz, K.-N.; Lindenborn-Fotinos, J.; Reddington, M.; Schwabe, U.; Olsson, R.A. (1987) Naunyn-Schmiedeberg's Arch. Pharmacol. 336, 204-210.
Martin, P.; Gero, T.W.; Potts, A.A.; Cusack, N.J. (1995) Drug Develop. Res. 36, 153-165.
Moaddel R., Cloix J.-F., Ertem G., Wainer I.W. (2002) Pharmaceutical Research 19(1) 104-107.
Nandanan, E.; Camaioni, E.; Jang, S.Y.; Kim, Y.C.; Cristalli, G.; Herdewijn, P.; Secrist 3rd, J.A.; Tiwari, K.N.; Mohanram, A.; Harden, T. K.; Boyer, J. L.; Jacobson, K.A (1999) J. Med. Chem. 42, 1625-1638.
Palczewski, K.; Kumasaka, T.; Hori, T.;. Behnke, C.A; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. (2000) Science, 289, 739-745.
Shaver, S.R.; Pendergast, W.; Siddiqui, S.M.; Yerxa, B.R.; Croom, D.K.; Dougherty, R.W.; James, M.K.; Jones, A.N.; Rideout, J. L. (1997) Nucleosides Nucleotides, 16, 1099-1102.
Simon, J.; Barnard, E.A. (2003) Acta Biol. Hung. 54(2), 191-201.
Sokolova, E.; Nistri, A.; Giniatullin, R. (2003) Neurosci. Lett. 338(3), 181-4.
van Rhee, A.M.; Fisher, B.; van Galen, P.J.M.; Jacobson, K.A. (1995) Drug Design Discov. 13, 133-154.
Vittori, S.; Lorenzen, A.; Stannek, C.; Costanzi, S.; Volpini, R.; IJerman, A.P.; von Frijtag Drabble Kunzel J.K.; Cristalli, G. (2000) J. Med. Chem. 53, 250-260.
Volonté, C.; Amadio, S.; Cavaliere, F.; D’Ambrosi, N.; Vacca, F.; Bernardi, G. (2003) CNS Neurol. Disord. 2, 61-72.
Volonté, C.; Ciotti, M.T.; D’Ambrosi, N.; Lockhart, B.; Spedding M. (1999) Neuropharmacoly 38, 1335-1342.
Volpini, R.; Costanzi, S.; Lambertucci, C.; Vittori, S.; Klotz, K.-N.; Lorenzen, A.; Cristalli, G. (2001) Bioorg. Med. Chem. Lett. 11, 1931-1934.
von Kügelgen, I.; Wetter A. (2000) Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 310-323.
Williams, M. (2001) (Abbracchio, M.P.; Williams, M. eds), pp. 407-434. Springer Verlag, Berlin-Heidelberg.
Zimmerman, H. (2001) Abbracchio. M.P., Williams, M., Eds.; Vol 151, Pat 1. Springer Verlag; Heidelberg; pp 209-250.

Parole Chiave

Chimica computazionale; Nuovi ligandi dei recettori P1 e P2; Nuovi antagonisti dei Recettori ionotropici del glutammato; Metodologie innovative di sintesi chimica; Predittività di attività biologica; Molecole attive a livello centrale